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http:WHAT THIS PAPER ADDS
Necrotizing soft tissue infections in intravenous drug users should be referred to vascular surgeons as there is a
signiﬁcant delay in treatment if patients are admitted under other specialties.Objective: To assess the short and long-term outcomes of necrotizing soft tissue infection (NSTI) in intravenous
drug users (IVDU) in a regional vascular centre.
Methods: This was a retrospective analysis of all IVDUs with NSTI admitted to the regional vascular surgical unit
between January 2009 and July 2014. Clinical outcome measures were interval between admission and surgery,
length of ITU/HDU and hospital stays, post-operative complications, in hospital and one year mortality.
Results: 25 patients were admitted. The median age was 39 years (range 30e53 years) with a female to male
ratio of 1:3.3. The median interval between admission and surgery was 23 hours (range 2e195 hours), however,
this was signiﬁcantly less when the admitting specialty was directly to vascular surgery (median 4 hours, range
2e7) compared with other specialties (median 38 hours, range 7e195 hours). Ten patients required HDU/ITU
care with a median duration of 4 days (range 1e12 days). Five patients (20%) required amputation, of whom two
(40%) had a prosthetic limb ﬁtted. There was one in hospital death (4%). Another patient died while awaiting
limb ﬁtting 4 months post discharge, giving a 1 year mortality of 8%.
Conclusions: NSTI in IVDUs carries high risk of amputation with a very low rate of limb ﬁtting. Intervention is
signiﬁcantly delayed when the admitting specialty is not vascular surgery, and half of these patients require HDU/
ITU care, with signiﬁcant morbidity and mortality. Early diagnosis and referral to vascular surgery is crucial in
management of these patients.
 2015 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
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Necrotizing soft tissue infection (NSTI) represents a spec-
trum of serious bacterial infections with a high mortality
rate of up to 73%.1e3 The superﬁcial appearance of NSTI
may easily be confused with superﬁcial cellulitis especially
in the early phase of the disease,4,5 so a high index of
clinical suspicion is required. NSTI may present with “hard”
signs such as crepitus, skin necrosis, haemodynamic insta-
bility, and gas on imaging; however, a signiﬁcant proportion
of patients will not have these hard signs. Given the rapid
spread of the infection throughout fascial planes and pro-
gression to a systemic inﬂammatory response syndrome,
septic shock and multiple organ failure are common
sequelae. Despite rapid and efﬁcacious early treatment,
death from the consequences of NSTI is a frequent occur-
rence. A spectrum of NSTI has been recognized inrresponding author. Department of Vascular Surgery, Ninewells Hospital,
il address: drdev@doctors.org.uk (D. Mittapalli).
-5884/ 2015 European Society for Vascular Surgery. Published by Else
//dx.doi.org/10.1016/j.ejvs.2015.02.002intravenous drug users (IVDU) e patients who undertake
intravenous illicit drug use. In Scotland, between April 2010
and April 2011, 4988 new patients who sought treatment
for drug addiction admitted to the use of heroin,6 a not
insigniﬁcant problem. More often than not the infections
are deep with involvement of fascia and muscle, and often
in close proximity or involving the surrounding vasculature.
Hence, these are termed necrotizing soft tissue infections
(NSTI), which not only includes necrotic infection at the
level of the superﬁcial fascia, subcutaneous fat, or deep
fascia (traditionally called necrotizing fasciitis),7,8 but also
deep cellulitis and myonecrosis. Necrotizing infections have
tended to be the domain of plastic and general surgeons;
however, in the IVDU patient, because of the possibility of
vessel injury, vascular surgeons have become increasingly
involved in their management.Dundee, DD1 9SY, UK.
vier Ltd. All rights reserved.
Table 1. Patient demographics, interventions, and outcomes.
Patient Age Sex Initial specialty Duration between
admission and
surgery
Number of
procedures
Complications ITU/HDU stay Microbiology Outcome
1 36 M Vasc 6 hours 4 Pneumonia 0 Staph. aureus, mixed anaerobes Debridement
2 38 M Ortho 62 hours 3 ARDS, pneumonia 12 N/A Hindquarter amputation
3 37 F Ortho 16 hours 3 Coagulopathy, pneumonia 4 Group B Strep, Citrobacter braakii Hindquarter amputation
4 32 M DGH/Gen Surg 75 hours 4 Multi-organ failure 11 Staph. aureus Debridement
5 30 F Vasc 4 hours 4 Coagulopathy, pneumonia 12 E. faecalis Hindquarter amputation
6 40 M DGH/Ortho N/A N/A Death N/A N/A Death
7 38 M Plastics 195 hours 1 AKI, pneumonia 0 Mixed anaerobes Debridement
8 39 F Vasc 5 hours 3 0 Staph. aureus AKA
9 33 M Med 34 hours 3 Respiratory failure, AKI 4 Group C Strep, Gram positive
bacillus, mixed anaerobes
Debridement
10 37 M Med 18 hrs 1 0 Staph. aureus Debridement
11 30 M Vasc 7 hours 1 Respiratory failure,
pneumonia
2 Staph. aureus, mixed anaerobes Triple ligation, debridement
12 29 M Gen Surg 38 hours 1 0 Staph. aureus Triple ligation, debridement
13 42 M DGH/Gen Surg 17 hours 1 0 Staph. aureus Triple ligation, AKA
14 38 F Vasc 3 hours 2 Pneumonia 1 Mixed anaerobes Triple ligation, debridement
15 47 M Med 44 hours 2 Multi-organ failure 3 Staph. epidermidis, Strep. aurarlis,
Strep. viridens, E. faecalis
Triple ligation, debridement
16 41 F Med 25 hours 4 0 Staph. aureus, mixed anaerobes Triple ligation, debridement
17 42 M Med 41 hours 1 0 No growth Triple ligation, debridement
18 49 M Med 21 hours 1 0 Diptheroids, anaerobic strep Debridement
19 53 M Med 123 hours 1 Thrombocytopenia 0 Staph. aureus, Group B strep Debridement
20 44 M Vasc 2 hours 1 Pneumonia 1 C. perfringens, Staph. aureus, mixed
anaerobes
Triple ligation, debridement
21 43 M Vasc 4 hours 1 0 Staph. aureus Triple ligation, debridement
22 31 F Gen Surg 43 hours 1 0 Group G strep., non-haemolytic strep. Debridement
23 35 M Med 27 hours 1 AKI 0 No growth Debridement
24 48 M Med 7 hours 1 0 C. perfringens Triple ligation, debridement
25 46 M Med 136 hours 2 AKI, lung abscess 8 Diptheroids, mixed anaerobes, Staph. epidermidis Triple ligation, debridement
M ¼ male; F ¼ female; DGH ¼ district general hospital; Ortho ¼ orthopaedics; Vasc ¼ vascular surgery; Gen Surg ¼ general surgery; Plastics ¼ plastic and reconstructive surgery;
Med ¼ general medicine; ARDS ¼ acute respiratory distress syndrome; AKI ¼ acute kidney injury; ITU ¼ intensive therapy unit; HDU ¼ high dependency unit; AKA ¼ above knee
amputation; N/A ¼ not applicable.
594
D
.
M
ittapalli
et
al.
Figure 1. (A) Transaxial section of computerized tomography showing left groin collection containing gas (yellow arrow), surrounding
superﬁcial femoral artery (large red arrow) and profunda femoris artery (small red arrow). (B) Coronal section of CT scan showing infected
collection containing gas (lower yellow arrow) surrounding the femoral artery bifurcation (red arrow), extending retro-inguinally deep into
the retroperitoneal space involving ilio-psoas muscle (middle yellow arrow) and tracking up to the left kidney superiorly and to the aorta
medially (upper yellow arrow).
Necrotizing Soft Tissue Infections in Intravenous Drug Users 595In this study, IVDU patients presenting to a single vascular
unit in Scotland with a diagnosis of NSTI are described
together with their subsequent management. The aim was
to critically appraise the characteristics and outcomes of
patients who attended between 2009 and 2014, and to
highlight the importance of timely diagnosis and surgical
intervention.METHODS
The study was a retrospective analysis of all patients with
necrotizing soft tissue infections secondary to IVDU admitted
to a regional vascular surgical unit between January 2009 and
July 2014. Patients with cellulitis or simple abscess/pseu-
doaneurysm with absent signs of a necrotizing process were
excluded. The data collected included: age, sex, site of
infection, laboratory, radiological and microbiological in-
vestigations, and interval between admission and surgical
intervention. The clinical outcome measures were duration
of hospital stay and intensive therapy unit (ITU)/surgical high
dependency unit (SHDU) stay, post-operative complications,
extent of debridement and amputation, in hospital and
1 year mortality rates. Comparisons between parameters
were performed using independent t test and one way
ANOVA, with p < .05 denoting signiﬁcance (Statistical
Package for the Social Sciences, v18).RESULTS
Twenty-ﬁve patients were admitted under the care of the
vascular surgical team with necrotizing soft tissue infections
secondary to IVDU, and included all patients with NSTI sec-
ondary to IVDU. The median age was 39 years (range 30e53
years), with the majority being male (n ¼ 19). The de-
mographics and outcomes are summarized in Table 1. The
median duration of follow up was 13 months (range 5e69
months). Irrespective of the admitting team, all patients were
reviewed by the admitting team consultant at least daily. Allthe patients had ipsilateral deep venous thrombosis (DVT)
proven on either duplex ultrasound scan or computerized to-
mography (CT) scan, with four patients diagnosed with
concomitant pulmonary emboli. Two patients (cases 3 and 5)
also had contralateral DVT. All the patients with proven DVT
were assumed to have an acute DVT because of difﬁculty in
determining the duration of the DVT in such patients. All were
treated with a 6 week course of subcutaneous dalteparin (200
iu/kg), but those with proven pulmonary emboli were treated
for 3 months. Only two patients (cases 8 and 13) who initially
presented with an infected pseudoaneurysm in conjunction
with NSTI underwent ligation of the femoral artery bifurcation
resulting in transfemoral amputation. Revascularization was
not deemed appropriate in these patients because of severe
ongoing systemic and localized sepsis requiring SHDU/ICU
support, and absence of a useable autologous conduit. Fig. 1A
and B demonstrates CT imaging of the NSTI in case 1.Biochemistry and haematology
Table 2 displays the haematological and biochemical pa-
rameters on admission. The majority (15/25, 60%) of pa-
tients had a white cell count (WCC) greater than 12  109/L
with all having raised C-reactive protein (CRP). Ten patients
had raised lactate of >2.2 mmol/L. Creatine kinase (CK) was
raised (>170 units/L) in all patients who had CK levels
checked (n ¼ 14/25, median 1069.5, range 192e18,500). All
patients had an albumin lower than 35 g/L (median 24;
range 13e34), and two thirds of patients had a serum so-
dium lower than normal (median 133, range 119e140).Microbiology/virology
Twenty-one of 25 patients had deﬁnitive microbiology from
tissue (Table 1). In one patient (case 2), the results could
not be traced. Two cases (cases 17 and 23) demonstrated no
growth on either aerobic or anaerobic blood cultures as
well as no growth on deep necrotic tissue taken during the
Table 2. Laboratory parameters.
Laboratory parameters Case 1 Case 2 Case 3 Case 4 Case 5 Case 6 Case 7 Case 8 Case 9 Case 10 Case 11 Case 12
White cell count (WCC) g/L 17.7 10.7 13.8 21.3 22.8 7.8 9.1 16.7 10.8 12.8 11.4 8.8
C-reactive protein (CRP) mg/L 421 68 78 348 394 264 343 98 91 110 241 95
Sodium (Na) mmol/L 132 136 134 134 127 132 131 133 136 140 130 132
Albumin (Alb) g/L 24 25 21 15 21 31 13 24 21 34 29 25
Blood urea nitrogen (BUN) mmol/L 15.1 17.4 6.7 19.4 28.8 5.8 14.6 15.1 4.2 3.3 3.9 3.7
Lactate mmol/L 2.1 7.6 2.1 9.3 8.5 1.4 6 4.1 5 2 4.1
Creatine kinase (CK) U/L 1534 4623 296 3501 16549 751 982 473 18500 411 655
596 D. Mittapalli et al.debridement. The fourth patient (case 6) did not have any
surgery as he died shortly after transfer to the vascular unit.
The microbiology was polymicrobial in most patients, with
the most common organism isolated being Staph-
ylocococcus aureus followed by mixed anaerobes and
Streptococcus sp. (group B, C and G). Entercoccus, Clos-
tridium, Citrobacter, and Diphtheroids were also isolated.Clinical outcomes
Level of peri-operative care: Ten of the patients (cases 2, 3,
4, 5, 9, 11, 14, 15, 20, and 25) required either level 2
(surgical high dependency unit) or level 3 (intensive therapy
unit) care (i.e. critical care support). Median duration of
level 2 or 3 care was 4 days (range 1e12 days). The most
common reasons for this were respiratory complications
followed by the need for vasopressor support along with
coagulation abnormalities. Table 3 compares the laboratory
parameters for patients who needed level 2 (HDU) or level 3
(ICU) care with those who did not. The WCC, CK, and lactate
levels were signiﬁcantly higher in patients who required
level 2 or 3 care compared with patients who did not. There
were no signiﬁcant differences in CRP, sodium, urea, and
albumin levels between the two groups. Table 4 summarizes
the need for cardiorespiratory and renal support in these
patients. All required ventilatory support, either invasive (4
patients) or non-invasive (6 patients). Non-invasive venti-
lation was either continuous or bi-level positive airway
pressure ventilation. Two of these patients required
inotropic support, whereas three patients required renal
replacement therapy in the form of haemodialysis.
Interval between admission and surgical intervention:
The overall median interval between admission and surgery
was 23 hours (range 2e195 hrs). The interval was signiﬁ-
cantly less where the admitting specialty was directly to
vascular surgery (median 4 hours, range 2e7 hours)
compared with other specialties (median 38 hours, range
7e195 hours), p¼.019.
Limb salvage: Five patients (20%) needed amputation, of
whom three required hip disarticulation (cases 2, 3, and 5 e
severe sepsis with extensive necrosis) and two a high
transfemoral (cases 8 and 13). Overall, 13 patients had tri-
ple vessel ligation of whom only two (15%, cases 8 and 13)
required a transfemoral amputation (profound limb
ischaemia with severe ongoing sepsis and lack of autolo-
gous conduit for arterial reconstruction). Of the ﬁve am-
putations, two patients (40%) had a prosthetic limb ﬁtted
(cases 5 and 13), while another patient with a transfemoralamputation (case 8) is still awaiting limb ﬁtting (delayed
because of ongoing failure to heal and patient non-
compliance). One patient died before limb ﬁtting and
another failed to attend for limb ﬁtting assessment despite
being sent repeated appointments.
Mortality: There was one (case 6) in hospital death (4%).
This patient was admitted under the orthopaedic surgeons
and was referred to vascular surgery 98 hours after admis-
sion, and was in a moribund state at the time of transfer. He
was unﬁt for any intervention because of multi-organ failure
and died in theatre reception soon after transfer despite ICU
support. Another patient died while awaiting limb ﬁtting 4
months post discharge (suspected overdose in the commu-
nity), resulting in a 1 year mortality of 8%.DISCUSSION
This series of 25 consecutive cases of necrotizing soft tissue
infection in intravenous drug abusers highlights the serious
sequelae of such infections, especially when a delay to
diagnosis and appropriate management is encountered. In
this region patients with complications secondary to IVDU
are increasingly referred to the vascular unit because of
decreasing expertise amongst general and orthopaedic
surgeons with regards to timely and accurate diagnosis and
management of infection close to major blood vessels, and
reduced expertise in performing major limb amputations.
Outwith vascular surgery, despite all the patients being
viewed daily by the admitting consultant, there were still
signiﬁcant delays in recognizing the condition.
Elliott et al.9 and Bilton et al.10 showed that delay in initial
debridement of NSTI is associated with increased morbidity
and mortality. This may be caused by delay in referral to the
appropriate surgical specialty, and by delay in investigations or
recognizing the severity of the disease with failure of under-
standing that outcomes depend on emergent surgical and
antimicrobial treatment.11e13 In the study patients, there was
signiﬁcant delay in surgical intervention when the admitting
specialtywas other than vascular surgery.Thismay have arisen
because of the delay in diagnosis due to the absence of clinical
signs and deceptively normal laboratory markers (especially in
cases 2, 12, 16, 19, 22, and 24). In some cases, despite
abnormal laboratorymarkers the diagnosiswas delayed (cases
4, 15, and 25). It would appear that a signiﬁcantly raised CK did
not arouse the suspicion of marked muscle necrosis.
Wall et al.14 reported that aWCC> 15.4 109/L (sensitivity
81%, speciﬁcity 76%), serum sodium< 135mmol/L (sensitivity
75%, speciﬁcity 100%) and blood urea nitrogen
Case 13 Case 14 Case 15 Case 16 Case 17 Case 18 Case 19 Case 20 Case 21 Case 22 Case 23 Case 24 Case 25 Median Range
12.9 13 16.3 9 12.1 12.9 7.7 11.1 12.2 9.8 14.3 10 20.2 12.2 7.7e22.8
247 44 271 146 149 169 285 256 257 223 165 219 304 223 44e421
126 128 129 135 128 132 136 134 135 136 139 135 119 133 119e140
21 23 27 26 25 22 24 25 18 20 24 19 19 24 13e34
13.1 4.3 3.8 2.3 18.9 15.3 4.6 4.2 7.2 3.9 7.9 4.9 47.1 6.7 2.3e47.1
3 0.6 1.9 2.4 1 1.3 0.7 1.1 0.9 0.9 5.1 2.1 0.6e9.3
1321 192 1157 1069.5 192e18500
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nated NSTI from non-NSTI (positive predictive value 26%,
negative predictive value 99%). However, laboratory parame-
ters can be deceptively normal, as only ﬁve of the present
series had a WCC> 14 109/L (the patient who died, case 6,
did not haveWCC>14 109/L or BUN> 15mg/dL). Of the ten
patients who needed peri-operative level 2 or 3 care, only
three (cases 4, 5, and 25) had raised WCC and BUN. Of the
patients who had their lactate and CK checked, nine had a
lactatewithin normal limits on admission (lactate<2mmol/L),
with all but one having a normal CK too (case 18). In the
present series, despite a consistent presentation (i.e. signs of
localized cellulitis and swelling), the biochemical parameters at
ﬁrst presentation were clearly not uniform. Wong et al. pro-
posed a numerical scoring system called LRINEC (Laboratory
Risk Indicator for NECrotizing fasciitis) to predict the NSTI15
based on laboratory parameters, which was strongly predic-
tive of necrotizing fasciitis (positive predictive value of 93.4%;
95% CI 85.5e97.2). A prospective observational study16 sug-
gested that tissue oxygen monitoring may predict NSTI,
reporting that tissue oxygen saturation of 70% or less has a
sensitivity of 100% with a speciﬁcity of 97%. However, thisTable 3. Comparison of laboratory parameters for HDU/ICU care versu
Laboratory parameters HDU/
Media
White cell count (109/L) 13.4
C-reactive protein (mg/L) 249
Sodium (mmol/L) 132
Albumin (g/L) 22
Blood urea nitrogen (mmol/L) 5.5
Lactate (mmol/L) 4.55
Creatine kinase (IU/L) 4062
Interval between admission and surgery (overall)
in hours
30
Table 4. Need for cardiorespiratory and renal support in patients requ
Case number Total duration
of ITU/HDU
Days on inotropes Number o
sessions
Case 2 12 4 3
Case 3 4 0 0
Case 4 11 0 2
Case 5 12 3 0
Case 9 4 0 0
Case 11 2 0 0
Case 14 1 0 0
Case 15 3 0 2
Case 20 1 0 0
Case 25 8 0 0study excluded patients with chronic venous insufﬁciency,
peripheral vascular disease, shock, and hypoxia.16
The microbiology of NSTIs in intravenous drug users is
often polymicrobial. Commonly implicated pathogens
include Staphylococcus aureus, Streptococcus pyogenes, an-
aerobes (including Clostridia, Bacteroides, and anaerobic
streptococci), and Gram negative aerobes. Monomicrobial
NSTIs are most commonly the result of S. pyogenes, Staph-
ylococcus aureus, and Clostridia species, the latter associated
with myonecrosis.17 There is little difference in the causative
organisms between drug users and the normal population
other than the anaerobes associated with necrotizing soft
tissue infections: Clostridia species are more commonly iso-
lated in patients who inject drugs.18 The regimen chosen
should provide activity against streptococci, staphylococci,
Gram negative organisms, anaerobes, and toxins.
High dose clindamycin has been shown to suppress toxin
production by S. pyogenes and Staphylococcus aureus
through inhibition of bacterial protein synthesis while also
modulating cytokine (e.g. TNF) production.19 It has broad
anti-anaerobe activity and should be included in all anti-
microbial regimens for suspected NSTI along with at leasts No HDU/ICU care.
ICU care No HDU/ICU care t test
n (range) Median (range) p
(10.7e22.8) 12.1 (7.7e17.7) .031
(44e394) 219 (95e421) .942
(119e136) 133 (126e140) .137
(15e29) 24 (13e34) .706
(3.8e47.1) 7.2 (2.3e18.9) .243
(0.6e9.3) 1.7 (0.9e6) .038
(296e18500) 703 (192e1534) .035
(2e136) 23 (4e195) .988
iring HDU/ITU care.
f haemodialysis Days on non-invasive
ventilation (NIV)
Days on ventilator
0 9
2 0
0 6
0 6
0 2
2 0
1 0
2 0
1 0
1 0
Table 5. Suggested antimicrobial regimens for the treatment of
NSTI.
1) Anti-staphylococcal agent (e.g.
ﬂucloxacillin) þ aminoglycoside þ
clindamycin
2) Broad spectrum b-lactam / b-lactamase
inhibitor (e.g. co-amoxiclav, piperacillin-
tazobactam) þ clindamycin
3) Fluoroquinolone (e.g. ciproﬂoxacin,
levoﬂoxacin) þ clindamycin
598 D. Mittapalli et al.one other agent to ensure adequate cover is provided for
Gram negative organisms. Suitable regimens for the treat-
ment of NSTI are summarized in Table 5. The pathogens
identiﬁed in the preset patients were similar to a previously
published case series in both IVDUs and the normal
population.18
In the present series, one patient died in hospital, which
is consistent with the published literature.3 Overall, 13 pa-
tients required an intervention for vessel involvement.
Twelve patients had an infected femoral pseudoaneurysm
at initial presentation (one of which was not seen on initial
imaging), while the other patient (case 1) bled from the
common femoral artery in theatre recovery. The artery
could be clearly seen in the wound following a further
debridement. All 13 required ligation of the common
femoral, superﬁcial femoral, and profunda femoris arteries,
with two proceeding to a major lower limb amputation.
The present study is limited as full data are not available
on all patients admitted to the vascular surgical or other
teams with complications secondary to IVDU requiring
intervention not related to necrotizing soft tissue infections
(i.e. drainage of simple abscess, ligation of false aneurysms,
cellulitis). All of the study patients were referred to a drug
rehabilitation programme (voluntary attendance), but
compliance was poor. The region runs a safe needle pro-
gramme; however, given the increasing severity of deep
intramuscular sepsis, there are concerns about the length of
the clean needles being offered. Interestingly, 14 patients
were positive for hepatitis C, with no patients positive for
hepatitis B or HIV (this may reﬂect a local hepatitis B
vaccination programme in high risk populations).
In summary, when patients were admitted under the care
of specialties other than vascular surgery, there was a sig-
niﬁcant delay inmaking the diagnosis and hence commencing
appropriate treatment in a large proportion of patients. It is
critical that clinicians who manage IVDU patients are aware
that NSTI maymasquerade as an innocuous focus of cellulitis.
Effective management, associated with reduced morbidity
and mortality, relies on quick diagnosis, aggressive debride-
ment, aggressive peri-operative supportive care, and appro-
priate antibacterial agents.20
Should necrotizing soft tissue infection secondary to
intravenous drug abuse be managed by a vascular surgicalservice? The authors feel that vascular surgeons should be
involved as early as possible, not always for deﬁnitive care
but because they have expertise in managing soft tissue
infections, vessel injuries, and amputations.
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Wrexham Maelor Hospital, Wrexham LL137TD, United KingdomA 59-year-old man was seen in the clinical setting with left-sided intermittent claudication. Five years previously, he had a
left femoro-popliteal bypass (reversed vein) for short distance claudication. Examination revealed an absent left femoral
pulse and a reasonably perfused leg. Magnetic resonance imaging showed a full-length occlusion of the left common iliac
and external iliac arteries but the vein graft was patent. The graft was fed by collateral circulation in the groin. Disease
progression usually leads to graft occlusion in patients with peripheral vascular disease. It is unusual for a bypass graft to
remain patent despite proximal arterial occlusion.vier Ltd. All rights reserved.
